Postnatal Antidepressant Effects on Periadolescent SERT Function by Voltammetry
Postnatal Antidepressant Effects on Periadolescent SERT Function by Voltammetry
批准号:
7642948
负责人:
ANNE MILASINCIC ANDREWS
金额:
$7.19万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2010-03-31
关键词:
AdolescenceAdolescentAdultAffinityAnimalsAntidepressive AgentsAnxietyArtsAttenuatedBehaviorBindingBinding SitesBirthBrainBrain StemBrain regionCarrier ProteinsDevelopmentElementsExposure toHippocampus (Brain)LifeMeasuresMethodsModelingMoodsMusParoxetinePharmaceutical PreparationsPhenotypePrincipal InvestigatorQuantitative AutoradiographyRattusResearch DesignRoleSelective Serotonin Reuptake InhibitorSerotoninSpeedSynaptosomesSystemTNFRSF5 geneTestingTimedepressiondepressive symptomsemerging adultpostnatalprogramspublic health relevanceradiochemicalreuptakeserotonin transportertyrosine kinase ABL1uptake
中文摘要
描述(由申请人提供):在出生后不久的特定时期用血清素再摄取抑制抗抑郁药(SRIs)治疗小鼠或大鼠,会导致成年后焦虑和抑郁样行为增加。在这里,我们将扩展我们的研究,使用伏安法来研究血清素转运体(SERT)在焦虑和抑郁中的作用,包括这个重要的产后血清素再摄取抑制模型。我们将使用计时电流测定法来确定产后SRI治疗引起的青春期和成年期血清素摄取率的变化。我们之前已经证明,使用高速计时电流法测量脑突触体中的血清素摄取优于传统的放射化学方法。我们还将利用定量放射自显影术来评估血清素转运体结合位点的变化,以确定SERT功能和表达的改变是否相关。最近有证据表明,正常动物在成年早期和中期海马SERT功能和表达增加。这项研究的设计将使我们能够调查这种发展轨迹是否在成年之前就开始了。我们还将确定它是否存在于海马以外的大脑区域,这些区域受血清素能系统的支配,对调节焦虑和情绪很重要。此外,我们将验证出生后服用SRIs会破坏青春期和成年期正常的SERT功能和表达发育的假设。这项研究的结果将使我们能够解释在青春期和/或成年时期发生的正常SERT发育的改变是否是导致出生后SRI暴露引起的表型改变的关键因素。这对我们理解5 -羟色胺能系统的正常发育以及与早期生活暴露于SRIs相关的改变轨迹产生了影响。公共卫生相关性:小鼠或大鼠出生后短期服用抑制血清素再摄取的抗抑郁药会导致成年后焦虑和抑郁行为升高。我们将使用最先进的电化学方法来确定停止药物治疗后血清素再摄取的减少是否会持续很长时间。我们将探讨早期接触抗抑郁药会改变血清素转运体功能和表达的正常发育。这项研究的结果将增加我们对正常大脑发育的理解,以及与早期接触抗抑郁药有关的发育轨迹的改变。
英文摘要
DESCRIPTION (provided by applicant): Treatment of mice or rats with serotonin reuptake inhibiting antidepressants (SRIs) during a specific period shortly after birth results in increased anxiety- and depressive-like behavior in adulthood. Here, we will extend our studies on the use of voltammetry methods to investigate the role of the serotonin transporter (SERT) in anxiety and depression to include this important model of postnatal inhibition of serotonin reuptake. We will use chronoamperometry to determine changes in serotonin uptake rates during periadolescence and adulthood arising from postnatal treatment with an SRI. We have demonstrated previously that the use of high-speed chronoamperometry to measure serotonin uptake in brain synaptosomes is superior to traditional radiochemical methods. We will also utilize quantitative autoradiography to evaluate changes in serotonin transporter binding sites to determine whether alterations in SERT function and expression are correlated. There is recent evidence that hippocampal SERT function and expression increase during early and middle adult periods in normal animals. The design of this study will allow us to investigate whether this developmental trajectory begins prior to adulthood. We will also determine whether it is present in brain regions other than hippocampus that are innervated by the serotonergic system and are important for modulating anxiety and mood. Moreover, we will test the hypothesis that postnatal administration of SRIs disrupts normal periadolescent and adult development of SERT function and expression. The results of this study will allow us to interpret whether alterations in normal SERT development occurring during adolescent and/or adult time frames are key elements contributing to the altered phenotype induced by postnatal SRI exposure. This has ramifications for our understanding of normal development of the serotonergic system and for altered trajectories related to early life exposure to SRIs. PUBLIC HEALTH RELEVANCE: Treatment of mice or rats with serotonin reuptake inhibiting antidepressants for a short period after birth leads to elevated anxiety and depressive behavior in adulthood. We will use a state-of-the-art electrochemical method to determine whether reductions in serotonin reuptake persist long after the cessation of drug treatment. We will explore the idea that early life exposure to antidepressants alters the normal development of serotonin transporter function and expression. The results of this study will increase our understanding of normal brain development and altered developmental trajectories related to early life exposure to antidepressants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Micro- to Nanoscale Neurochemical Sensors
-
批准号:10319427
-
项目类别:
-
资助金额:$7.2万
-
财政年份:2017
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Micro- to Nanoscale Neurochemical Sensors
-
批准号:9369813
-
项目类别:
-
资助金额:$119.45万
-
财政年份:2017
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Micro- to Nanoscale Neurochemical Sensors
-
批准号:10001487
-
项目类别:
-
资助金额:$114.06万
-
财政年份:2017
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Micro- to Nanoscale Neurochemical Sensors
-
批准号:9768423
-
项目类别:
-
资助金额:$112.51万
-
财政年份:2017
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Postnatal Antidepressant Effects on Periadolescent SERT Function by Voltammetry
-
批准号:7796765
-
项目类别:
-
资助金额:$7.7万
-
财政年份:2009
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Voltammetry of 5-HT Transmission in Psychiatric & Degenerative Disease Models
-
批准号:7835070
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2009
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Mapping and Serotonergic Regulation of Multiple BDNF Transcript Isoforms in Mice
-
批准号:7258654
-
项目类别:
-
资助金额:$6.66万
-
财政年份:2007
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Sert Expression and Survival of Serotonin Neurons
-
批准号:6598972
-
项目类别:
-
资助金额:$6.68万
-
财政年份:2003
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Sert Expression and Survival of Serotonin Neurons
-
批准号:6733543
-
项目类别:
-
资助金额:$6.9万
-
财政年份:2003
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Voltammetry of 5-HT Transmission in Psychiatric & Degenerative Disease Models
-
批准号:7804470
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2001
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
5-HT Reuptake in SERT Knockout Mice by Voltammetry
-
批准号:6686402
-
项目类别:
-
资助金额:$20.67万
-
财政年份:2001
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Voltammetry of 5-HT Transmission in Psychiatric & Degenerative Disease Models
-
批准号:7448604
-
项目类别:
-
资助金额:$23.46万
-
财政年份:2001
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Voltammetry of 5-HT Transmission in Psychiatric & Degenerative Disease Models
-
批准号:7595918
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2001
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
5-HT Reuptake in SERT Knockout Mice by Voltammetry
-
批准号:6422671
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2001
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Voltammetry of 5-HT Transmission in Psychiatric & Degenerative Disease Models
-
批准号:8136149
-
项目类别:
-
资助金额:$22.74万
-
财政年份:2001
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
5-HT Reuptake in SERT Knockout Mice by Voltammetry
-
批准号:6620872
-
项目类别:
-
资助金额:$20.69万
-
财政年份:2001
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
Voltammetry of 5-HT Transmission in Psychiatric & Degenerative Disease Models
-
批准号:7197240
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2001
-
负责人:ANNE MILASINCIC ANDREWS
-
依托单位:
海外基金